Merck (MRK) Raw Materials (2009 - 2012)
Merck's (MRK) quarterly Raw Materials came in at $5.7 billion in Q2 2012, down 5.48% year-over-year from $6.0 billion in Q3 2011, and down 0.9% quarter-over-quarter from $5.8 billion in Q1 2012.
Analysis
Merck (MRK) Raw Materials (2009 - 2012) Analysis & Trends
Merck (MRK) has reported Raw Materials for 4 consecutive years, with $5.7 billion the latest figure, recorded in Q2 2012.
- On a quarterly basis, Raw Materials fell 5.48% year-over-year to $5.7 billion in Q2 2012; TTM through Jun 2012 was $5.7 billion, a 5.48% decrease from a year earlier, with the FY2011 full-year figure at $5.4 billion, down 0.97% from the prior year.
- Raw Materials was $5.7 billion for Q2 2012 at Merck, down from $5.8 billion in the prior quarter.
- Over five years, Raw Materials peaked at $6.6 billion in Q4 2009 and troughed at $5.3 billion in Q2 2010.
- A 4-year average of $5.7 billion and a median of $5.7 billion in 2012 frame the typical range for Raw Materials.
- Across the five-year window, Raw Materials declined 17.23% in 2010 and grew 13.66% in 2011, its largest moves.
- Over 4 years, Raw Materials stood at $6.6 billion in 2009, then decreased by 17.23% to $5.4 billion in 2010, then declined by 0.97% to $5.4 billion in 2011, then increased by 5.73% to $5.7 billion in 2012.
- The last three Raw Materials figures came in at $5.7 billion (Q2 2012), $5.8 billion (Q1 2012), and $5.4 billion (Q4 2011), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.02 Bn | 620.27 Bn | 17.26 Bn |
| 2 | AbbVie | 445.75 Bn | 439.18 Bn | 12.70 Bn |
| 3 | Merck | 357.52 Bn | 350.38 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.31 Bn | 259.62 Bn | 11.24 Bn |
| 5 | Pfizer | 156.58 Bn | 144.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.75 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.04 Bn | 43.04 Bn | - |
| 8 | Incyte | 24.61 Bn | 20.07 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.30 Bn | 18.64 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.80 Bn | 15.42 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2012 | 5.71 Bn |
| Mar 31, 2012 | 5.76 Bn |
| Dec 31, 2011 | 5.40 Bn |
| Sep 30, 2011 | 5.80 Bn |
| Jun 30, 2011 | 6.04 Bn |
| Mar 31, 2011 | 5.80 Bn |
| Dec 31, 2010 | 5.45 Bn |
| Sep 30, 2010 | 5.44 Bn |
| Jun 30, 2010 | 5.31 Bn |
| Dec 31, 2009 | 6.58 Bn |